3-(2,5-difluorophenyl)-5-[(3S)-3-fluoropyrrolidin-1-yl]-N-(6-propan-2-yl-3-pyridinyl)pyridine-4-carboxamide
C24H23F3N4O — CID 155557550
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(2,5-difluorophenyl)-5-[(3S)-3-fluoropyrrolidin-1-yl]-N-(6-propan-2-yl-3-pyridinyl)pyridine-4-carboxamide
3-(2,5-difluorophenyl)-5-[(3S)-3-fluoropyrrolidin-1-yl]-N-(6-propan-2-yl-3-pyridinyl)pyridine-4-carboxamide (PubChem CID 155557550) has the molecular formula C24H23F3N4O and a molecular weight of 440.47 g/mol. Its IUPAC name is 3-(2,5-difluorophenyl)-5-[(3S)-3-fluoropyrrolidin-1-yl]-N-(6-propan-2-yl-3-pyridinyl)pyridine-4-carboxamide.
Molecular Properties
| Compound Name | 3-(2,5-difluorophenyl)-5-[(3S)-3-fluoropyrrolidin-1-yl]-N-(6-propan-2-yl-3-pyridinyl)pyridine-4-carboxamide |
|---|---|
| PubChem CID | 155557550 |
| Molecular Formula | C24H23F3N4O |
| Molecular Weight | 440.47 g/mol |
| Exact Mass | 440.18 |
| IUPAC Name | 3-(2,5-difluorophenyl)-5-[(3S)-3-fluoropyrrolidin-1-yl]-N-(6-propan-2-yl-3-pyridinyl)pyridine-4-carboxamide |
| SMILES | CC(C)c1ccc(NC(=O)c2c(-c3cc(F)ccc3F)cncc2N2CC[C@H](F)C2)cn1 |
| InChI | InChI=1S/C24H23F3N4O/c1-14(2)21-6-4-17(10-29-21)30-24(32)23-19(18-9-15(25)3-5-20(18)27)11-28-12-22(23)31-8-7-16(26)13-31/h3-6,9-12,14,16H,7-8,13H2,1-2H3,(H,30,32)/t16-/m0/s1 |
| InChIKey | RHAQYJOKWJFNME-INIZCTEOSA-N |
| XLogP | 5.35 |
| TPSA | 58.12 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 440.47 |
| LogP ≤ 5 | 5.35 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155557550 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.